Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma

Anticancer Research

Volumn 26, Issue 6 C, 2006, Pages 4937-4942

  Segura Sánchez, Juan ^a   González Cámpora, Ricardo ^b   Pareja Megía, María Jesús ^b   García Escudero, Antonio ^b   Galera Ruiz, Hugo ^b   López Beltrán, Antonio ^c  

^a HOSPITAL INFANTA MARGARITA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Chromosome 12; FISH; Immunohistochemistry; Liposarcoma

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PROTEIN MDM2; PROTEIN P53;

ADULT; AGED; ARTICLE; CHROMOSOME 12; CHROMOSOME MUTATION; CHROMOSOME NUMBER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE LOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MALE; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CHROMOSOMES, HUMAN, PAIR 12; COHORT STUDIES; CYCLIN-DEPENDENT KINASE 4; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOSARCOMA; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33845917627     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Weiss SW and Goldblum JR: Enzinger and Weiss's Soft Tissue Tumours. 4th ed. St Louis, Mosby, pp. 571-694, 2001.
2. Fletcher CDM, Unni KK and Mertens F (eds.): World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Soft Tissue and Bone. IARC Press: Lyon, France, pp. 19-44, 2002.
3. Evans H: Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol 3: 507-523, 1979.
4. Kempson R, Fletcher CDM, Evans H, Henricks MR and Sibley RK: Lipomatous Tumors. Tumors of the Soft Tissues. Atlas of Tumor Pathology. Third edition; N°30. AFIP. Washington DC, pp. 187-237, 2001.
5. Henricks WH, Chu YC, Goldblum JR and Weiss SW: Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 21: 271-81, 1997.
6. Fletcher CD, Akerman M, Dal Cin P, de Wever I, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, van den Berghe H, van de Ven W, Vanni R and Willen H: Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol 148: 623-630, 1996.
7. Meis-Kindblom JM, Sjogren H, Kindblom LG, Peydro-Mellquist A, Roijer E, Aman P and Stenman G: Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis. Virchows Arch 439: 141-151, 2001.
8. Weiss SW and Rao VK: Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of "dedifferentiation". Am J Surg Pathol 16: 1051-1058,1992.
9. Nascimento AG: Dedifferentiated liposarcoma. Semin Diagn Pathol 18: 263-266, 2001.
10. McCormick D, Mentzel T, Beham A and Fletcher CD: Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol 18: 1213-1223, 1994.
11. Hostein I, Pelmus M, Aurias A, Pedeutour F, Mathoulin-Pelissier S and Coindre JM: Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas. J Pathol 202: 95-102, 2004.
12. Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagace R, Aurias A, Hostein I and Coindre JM: MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 29: 1340-347, 2005.
13. Pilotti S, Della Torre G, Lavarino C, Sozzi G, Minoletti F, Vergani B, Azzarelli A, Rilke F and Pierotti MA: Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22. J Pathol 185: 188-190, 1998.
14. Adachi T, Oda Y, Sakamoto A, Saito T, Tamiya S, Masuda K and Tsuneyoshi M: Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component. Int J Surg Pathol 9: 99-109, 2001.
15. Pilotti S, Della Torre G, Lavarino C, Di Palma S, Sozzi G, Minoletti F, Rao S, Pasquini G, Azzarelli A, Rilke F and Pierotti MA: Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol 181: 14-24, 1997.
16. Tsuji T, Fukuda T, Tamiya S and Tsuneyoshi M: Dedifferentiated components versus well-differentiated components in Dedifferentiated liposarcoma: a comparative study of their proliferative activity and interphase cytogenetics using MIB-1 immunostaining and fluorescence in situ hybridization. Inter J Surg Pathol 7: 1-10, 1999.